$174.00
3.03%
Nasdaq, Sep 19, 10:11 pm CET

ICON Plc Stock price

$174.00
-5.64 3.14% 1M
-10.48 5.68% 6M
-35.71 17.03% YTD
-126.92 42.18% 1Y
-27.74 13.75% 3Y
-3.08 1.74% 5Y
+93.91 117.26% 10Y
+163.38 1,538.42% 20Y
Nasdaq, Closing price Fri, Sep 19 2025
-5.43 3.03%

Key metrics

Basic
Market capitalization
$13.5b
Enterprise Value
$16.6b
Net debt
$3.0b
Cash
$390.4m
Shares outstanding
77.8m
Valuation (TTM | estimate)
P/E
17.4 | 12.8
P/S
1.7 | 1.7
EV/Sales
2.1 | 2.0
EV/FCF
16.7
P/B
1.4
Financial Health
Equity Ratio
56.4%
Return on Equity
8.3%
ROCE
8.3%
ROIC
8.3%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$8.1b | $8.1b
EBITDA
$1.6b | $1.6b
EBIT
$1.2b | $1.4b
Net Income
$794.3m | $1.1b
Free Cash Flow
$989.6m
Growth (TTM | estimate)
Revenue
-2.9% | -1.6%
EBITDA
-9.8% | -5.8%
EBIT
3.8% | 17.4%
Net Income
11.2% | 33.3%
Free Cash Flow
-16.3%
Margin (TTM | estimate)
Gross
28.7%
EBITDA
19.2% | 19.8%
EBIT
14.4%
Net
9.8% | 13.0%
Free Cash Flow
12.2%
More
EPS
$10.0
FCF per Share
$12.7
Short interest
3.0%
Employees
42k
Rev per Employee
$200.0k
Show more

Is ICON Plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,012 stocks worldwide.

ICON Plc Stock Analysis

Unlock Scores for Free

Analyst Opinions

25 Analysts have issued a ICON Plc forecast:

17x Buy
68%
8x Hold
32%

Analyst Opinions

25 Analysts have issued a ICON Plc forecast:

Buy
68%
Hold
32%

Financial data from ICON Plc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
8,090 8,090
3% 3%
100%
- Direct Costs 5,772 5,772
1% 1%
71%
2,318 2,318
6% 6%
29%
- Selling and Administrative Expenses 767 767
1% 1%
9%
- Research and Development Expense - -
-
-
1,551 1,551
10% 10%
19%
- Depreciation and Amortization 383 383
36% 36%
5%
EBIT (Operating Income) EBIT 1,168 1,168
4% 4%
14%
Net Profit 794 794
11% 11%
10%

In millions USD.

Don't miss a Thing! We will send you all news about ICON Plc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ICON Plc Stock News

Neutral
Business Wire
18 days ago
DUBLIN--(BUSINESS WIRE)--ICON Announces CEO Transition.
Neutral
Business Wire
20 days ago
DUBLIN--(BUSINESS WIRE)--ICON plc to Participate at Upcoming Investor Conferences.
Positive
MarketBeat
20 days ago
In the world of healthcare stocks, a major innovation, new medical device, or successful drug treatment can cement a firm's position as a leader. Unfortunately, many firms chase after these goals and never achieve them.
More ICON Plc News

Company Profile

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

Head office Ireland
CEO Stephen Cutler
Employees 41,900
Founded 1989
Website www.iconplc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today